Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: Development, validation and implementation of an mHealth tool (MyCyFAPP)

BMJ Open

Volumn 7, Issue 3, 2017, Pages

  Calvo Lerma, Joaquim ^a,b   Martinez Jimenez, Celia P ^c,d   Lázaro Ramos, Juan Pablo ^e   Andrés, Ana ^b   Crespo Escobar, Paula ^a   Stav, Erlend ^f   Schauber, Cornelia ^g   Pannese, Lucia ^h   Hulst, Jessie M ⁱ   Suárez, Lucrecia ^j   Colombo, Carla ^k   Barreto, Celeste ^l   De Boeck, Kris ^m   Ribes Koninckx, Carmen ^a  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e Soluciones Tecnolégicas para la Salud y El Bienestar   (Spain)

^f SINTEF   (Norway)

^g YOUSE GmbH   (Germany)

^h imaginary srl   (Italy)

ⁱ SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^j Servicio Madrileño de Salud Red de Investigación en Servicios de Salud en Enfermedades Crónicas   (Spain)

^k UNIVERSITY OF MILAN   (Italy)

^l INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^m UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CHILD NUTRITION; CLINICAL ASSESSMENT; COHORT ANALYSIS; CYSTIC FIBROSIS; DIET THERAPY; EUROPE; FEEDING BEHAVIOR; FOLLOW UP; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOBILE APPLICATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; QUALITY OF LIFE; SELF CARE; SOCIAL WELFARE; SUBSTITUTION THERAPY; CHILD WELFARE; FEMALE; INFANT; MALE; PRESCHOOL CHILD; PROCEDURES; PROGRAM EVALUATION; TELEMEDICINE; VALIDATION STUDY;

ADOLESCENT; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; FEMALE; HUMANS; INFANT; MALE; PROGRAM EVALUATION; SELF-MANAGEMENT; TELEMEDICINE;

EID: 85015733435     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-014931     Document Type: Article

References (21)

1. Colombo C, Littlewood J. The implementation of standards of care in Europe: state of the art. J Cyst Fibros 2011;10(Suppl 2):S7-S15.
2. Gaskin KJ. Nutritional care in children with cystic fibrosis: are our patients becoming better & quest. Eur J Clin Nutr 2013;67:558-64.
3. Stephenson AL, Mannik LA, Walsh S, et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr 2013;97:872-7.
4. Kerem E, Viviani L, Zolin A, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur Respir J 2014;43:125-33.
5. Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Experiment Gastroenterol 2011:4:55-73.
6. Sikkens EC, Cahen DL, Kuipers EJ, et al. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:337-47.
7. Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007;56: 1153-63.
8. Woestenenk JW, van der Ent CK, Houwen RH. Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr 2015;61:355-60.
9. Haupt ME, Kwasny MJ, Schechter MS, et al. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis. J Pediatr 2014;164:1110-15. e1.
10. Borowitz D, Durie PR, Clarke LL, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41:273-85.
11. Borowitz D, Gelfond D, Maguiness K, et al. Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration. J Cyst Fibros 2013;12:784-5.
12. Turck D, Braegger CP, Colombo C, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, adults with cystic fibrosis. Clin Nutr 2016;35:557-77.
13. Li Y, Hu M, McClements DJ. Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: proposal for a standardised pH-stat method. Food Chem 2011;126: 498-505.
14. Hunter JE. Studies on effects of dietary fatty acids as related to their position on triglycerides. Lipids 2001;36:655-68.
15. Stuknyte M, Cattaneo S, Masotti F, et al. Occurrence and fate of ACE-inhibitor peptides in cheeses and in their digestates following in vitro static gastrointestinal digestion. Food Chem 2015;168: 27-33.
16. Parada J, Aguilera JM. Food microstructure affects the bioavailability of several nutrients. J Food Sci 2007;72:R21-32.
17. Singh H, Ye A, Horne D. Structuring food emulsions in the gastrointestinal tract to modify lipid digestion. Prog Lipid Res 2009;48:92-100.
18. Zhu X, Ye A, Verrier T, et al. Free fatty acid profiles of emulsified lipids during in vitro digestion with pancreatic lipase. Food Chem 2013;139:398-404.
19. Lesmes U, McClements DJ. Controlling lipid digestibility: response of lipid droplets coated by -lactoglobulin-dextran Maillard conjugates to simulated gastrointestinal conditions. Food Hydrocolloids 2012;26:221-30.
20. Giang TM, Gaucel S, Brestaz P, et al. Dynamic modeling of in vitro lipid digestion: individual fatty acid release and bioaccessibility kinetics. Food Chem 2016;194:1180-8.
21. Nieva-Echevarriá B, Goicoechea E, Manzanos MJ. A study by 1H NMR on the influence of some factors affecting lipid in vitro digestion. Food Chem 2016;211:17-26.